0708 GMT - RELX is likely to maintain its full-year and medium-term guidance for improved growth, J.P. Morgan analysts write in a note. The London-listed information-and-analytics group is set to report its first-half results on Thursday. The analysts anticipate 7% organic growth and 0.3 percentage points of margin improvement, with subscription growth in the scientific, technical & medical unit up to 6% in the first half. Looking ahead, the U.S. bank expects organic growth to accelerate to 8% from next year, partly boosted by an AI-driven acceleration to legal and scientific, technical & medical divisions. Shares aredown 1% at 24.92 pounds.(najat.kantouar@wsj.com)
(END) Dow Jones Newswires
July 21, 2026 03:08 ET (07:08 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments